MET and pancreatic neoplasm: CDK1 (Figure 5A), DSC2 (Figure 5B), ERO1A (Figure 5C), MET (Figure 5D), PYGL (Figure 5E), and SLC35A3 (Figure 5F) were highly expressed while CHST12 (Figure 5G) was decreased in pancreatic cancer.